Skip to main content

Owens & Minor Inc (ACH)

Health Services Health Care
Stock AI

Financial Metrics

Price to Earnings-0.31x
Revenue Growth (1Y)-92.11%
Debt to Equity-3.12x

Strengths

Stock Chart

Valuation

Owens & Minor Inc is overvalued

News

All
Press Releases
News
Filings
Accendra Health Announces Adoption of Tax Asset Preservation Plan To Protect Long Term Shareholder Value
August 10, 2026Accendra Health Announces Adoption of Tax Asset Preservation Plan To Protect Long Term Shareholder Value
Accendra Health Reports Second Quarter 2026 Financial Results
August 10, 2026Accendra Health Reports Second Quarter 2026 Financial Results
Accendra Health’s Ed Pesicka Announces Intent to Retire; Board of Directors Has Begun Successor Search
August 10, 2026Accendra Health’s Ed Pesicka Announces Intent to Retire; Board of Directors Has Begun Successor Search
10-Q Quarterly Report for 2026 Q2
August 10, 202610-Q Quarterly Report for 2026 Q2
Accendra Health Announces Leadership Appointments in IT and Procurement
July 27, 2026Accendra Health Announces Leadership Appointments in IT and Procurement
Accendra Health Announces Second Quarter 2026 Earnings Release Date and Conference Call
July 27, 2026Accendra Health Announces Second Quarter 2026 Earnings Release Date and Conference Call
Accendra Health Announces Expiration and Final Results of Offers and Consent Solicitations
June 24, 2026Accendra Health Announces Expiration and Final Results of Offers and Consent Solicitations
Accendra Health Announces Early Results of Offers and Consent Solicitations
June 10, 2026Accendra Health Announces Early Results of Offers and Consent Solicitations
Accendra Health Announces Offers and Consent Solicitations
May 22, 2026Accendra Health Announces Offers and Consent Solicitations
Accendra Health Reports First Quarter 2026 Financial Results and Announces Comprehensive Balance Sheet Optimization Transaction
May 11, 2026Accendra Health Reports First Quarter 2026 Financial Results and Announces Comprehensive Balance Sheet Optimization Transaction
10-Q Quarterly Report for 2026 Q1
May 11, 202610-Q Quarterly Report for 2026 Q1
Accendra Health Announces First Quarter 2026 Earnings Release Date and Conference Call
May 01, 2026Accendra Health Announces First Quarter 2026 Earnings Release Date and Conference Call
10-K Annual Report for 2025 FY
February 20, 202610-K Annual Report for 2025 FY
Owens & Minor, Inc. Completes Sale of Products & Healthcare Services Business to Platinum Equity
December 31, 2025Owens & Minor, Inc. Completes Sale of Products & Healthcare Services Business to Platinum Equity
Owens & Minor Announces Corporate Name Change to Accendra Health, Inc.
December 18, 2025Owens & Minor Announces Corporate Name Change to Accendra Health, Inc.
Owens & Minor to Present at Upcoming Investor Conferences on December 2, 2025
December 02, 2025Owens & Minor to Present at Upcoming Investor Conferences on December 2, 2025
10-Q Quarterly Report for 2025 Q3
October 31, 202510-Q Quarterly Report for 2025 Q3
Owens & Minor Reports Third Quarter 2025 Financial Results
October 30, 2025Owens & Minor Reports Third Quarter 2025 Financial Results
Owens & Minor Announces Date and Time Change of Third Quarter 2025 Financial Results and Conference Call
October 16, 2025Owens & Minor Announces Date and Time Change of Third Quarter 2025 Financial Results and Conference Call
Owens & Minor Announces Definitive Agreement to Divest Products & Healthcare Services Segment to Platinum Equity for $375mm in Cash and a Retained Equity Stake
October 07, 2025Owens & Minor Announces Definitive Agreement to Divest Products & Healthcare Services Segment to Platinum Equity for $375mm in Cash and a Retained Equity Stake
Gold Down Over 2%; Monday.com Shares Tumble After Q2 Results
August 11, 2025Gold Down Over 2%; Monday.com Shares Tumble After Q2 Results
Owens & Minor Pushes Forward, Transitions To 'Pure-Play' Patient Direct Business
August 11, 2025Owens & Minor Pushes Forward, Transitions To 'Pure-Play' Patient Direct Business
US Stocks Mixed; Owens & Minor Posts Downbeat Earnings
August 11, 2025US Stocks Mixed; Owens & Minor Posts Downbeat Earnings
Top Wall Street Forecasters Revamp Owens & Minor Expectations Ahead Of Q2 Earnings
August 11, 2025Top Wall Street Forecasters Revamp Owens & Minor Expectations Ahead Of Q2 Earnings
Owens & Minor Reports Second Quarter 2025 Financial Results
August 11, 2025Owens & Minor Reports Second Quarter 2025 Financial Results
10-Q Quarterly Report for 2025 Q2
August 11, 202510-Q Quarterly Report for 2025 Q2
Owens & Minor Announces Second Quarter 2025 Earnings Release Date and Conference Call
August 04, 2025Owens & Minor Announces Second Quarter 2025 Earnings Release Date and Conference Call
Crude Oil Moves Higher; Ciena Posts Downbeat Earnings
June 05, 2025Crude Oil Moves Higher; Ciena Posts Downbeat Earnings
Owens & Minor and Rotech Healthcare Mutually Agree to Terminate Previously Announced Acquisition
June 05, 2025Owens & Minor and Rotech Healthcare Mutually Agree to Terminate Previously Announced Acquisition
Wall Street Rallies After US Seals First Trade Deal: 'You Better Go Out And Buy Stock,' Trump Says
May 08, 2025Wall Street Rallies After US Seals First Trade Deal: 'You Better Go Out And Buy Stock,' Trump Says
Why Is Owens & Minor Stock Trading Lower On Thursday?
May 08, 2025Why Is Owens & Minor Stock Trading Lower On Thursday?
Owens & Minor Reports First Quarter 2025 Financial Results
May 08, 2025Owens & Minor Reports First Quarter 2025 Financial Results
10-Q Quarterly Report for 2025 Q1
May 08, 202510-Q Quarterly Report for 2025 Q1
Owens & Minor Announces First Quarter 2025 Earnings Release Date and Conference Call
May 01, 2025Owens & Minor Announces First Quarter 2025 Earnings Release Date and Conference Call
Owens & Minor Announces Major Innovations to Products & Healthcare Services Network
April 09, 2025Owens & Minor Announces Major Innovations to Products & Healthcare Services Network
Owens & Minor Announces Upsize and Pricing of Senior Secured Notes Offering
April 02, 2025Owens & Minor Announces Upsize and Pricing of Senior Secured Notes Offering
Owens & Minor Announces Launch of Senior Secured Notes Offering
March 26, 2025Owens & Minor Announces Launch of Senior Secured Notes Offering
Healthcare Logistics Firm Owens & Minor Reports Better-Than-Expected Q4 Earnings, Plans To Repurchase $100 Million In Shares
February 28, 2025Healthcare Logistics Firm Owens & Minor Reports Better-Than-Expected Q4 Earnings, Plans To Repurchase $100 Million In Shares
Nasdaq Tumbles Over 500 Points As Nvidia Plunges Post Q4 Results: Investor Sentiment Declines Further, Greed Index Remains In 'Extreme Fear' Zone
February 28, 2025Nasdaq Tumbles Over 500 Points As Nvidia Plunges Post Q4 Results: Investor Sentiment Declines Further, Greed Index Remains In 'Extreme Fear' Zone
HP, Dell Technologies And 3 Stocks To Watch Heading Into Friday
February 28, 2025HP, Dell Technologies And 3 Stocks To Watch Heading Into Friday
Owens & Minor Reports Fourth Quarter & Full Year Financial Results and Announces Sale Process Underway for Products & Healthcare Services Segment
February 28, 2025Owens & Minor Reports Fourth Quarter & Full Year Financial Results and Announces Sale Process Underway for Products & Healthcare Services Segment
10-K Annual Report for 2024 FY
February 28, 202510-K Annual Report for 2024 FY
Owens & Minor Launches ByramConnect Digital Health Platform for Diabetes and Other Chronic Health Conditions
February 11, 2025Owens & Minor Launches ByramConnect Digital Health Platform for Diabetes and Other Chronic Health Conditions
Dow Trims Losses After Trump Delays Mexico, Canada Tariffs: Greed Index Remains In 'Fear' Zone
February 04, 2025Dow Trims Losses After Trump Delays Mexico, Canada Tariffs: Greed Index Remains In 'Fear' Zone
Crude Oil Moves Higher; Owens & Minor Shares Plummet
February 03, 2025Crude Oil Moves Higher; Owens & Minor Shares Plummet
Dow Falls 150 Points; ISM Manufacturing PMI Rises In January
February 03, 2025Dow Falls 150 Points; ISM Manufacturing PMI Rises In January
Owens & Minor Stock Dips On Mixed Q4 Preliminary Results & $310 Million Apria Goodwill Charge: Details
February 03, 2025Owens & Minor Stock Dips On Mixed Q4 Preliminary Results & $310 Million Apria Goodwill Charge: Details
Owens & Minor Launches Financing for Rotech Acquisition and Provides Preliminary Fourth Quarter and Full Year 2024 Financial Results Ahead of Investor Meetings
February 03, 2025Owens & Minor Launches Financing for Rotech Acquisition and Provides Preliminary Fourth Quarter and Full Year 2024 Financial Results Ahead of Investor Meetings
Owens & Minor to Present at Upcoming Investor Conferences
December 02, 2024Owens & Minor to Present at Upcoming Investor Conferences
Owens & Minor Reports Third Quarter 2024 Financial Results
November 04, 2024Owens & Minor Reports Third Quarter 2024 Financial Results
10-Q Quarterly Report for 2024 Q3
November 04, 202410-Q Quarterly Report for 2024 Q3
Owens & Minor Announces Third Quarter 2024 Earnings Release Date and Conference Call
October 21, 2024Owens & Minor Announces Third Quarter 2024 Earnings Release Date and Conference Call
10-Q Quarterly Report for 2024 Q2
August 02, 202410-Q Quarterly Report for 2024 Q2
10-Q Quarterly Report for 2024 Q1
May 03, 202410-Q Quarterly Report for 2024 Q1
10-K Annual Report for 2023 FY
February 20, 202410-K Annual Report for 2023 FY
10-Q Quarterly Report for 2023 Q3
November 03, 202310-Q Quarterly Report for 2023 Q3
10-Q Quarterly Report for 2023 Q2
August 04, 202310-Q Quarterly Report for 2023 Q2
10-Q Quarterly Report for 2023 Q1
May 05, 202310-Q Quarterly Report for 2023 Q1
10-K Annual Report for 2022 FY
February 28, 202310-K Annual Report for 2022 FY
10-Q Quarterly Report for 2022 Q3
November 02, 202210-Q Quarterly Report for 2022 Q3
10-Q Quarterly Report for 2022 Q2
August 03, 202210-Q Quarterly Report for 2022 Q2
10-Q Quarterly Report for 2022 Q1
May 04, 202210-Q Quarterly Report for 2022 Q1
10-K Annual Report for 2021 FY
February 23, 202210-K Annual Report for 2021 FY
10-Q Quarterly Report for 2021 Q3
November 03, 202110-Q Quarterly Report for 2021 Q3

A. Company Overview

Owens & Minor, Inc. is a global healthcare solutions company founded in 1882 and headquartered in Richmond, Virginia. The company operates as a Fortune 500 entity, focusing on the manufacturing and distribution of medical supplies, along with innovative technology services that deliver value throughout the healthcare supply chain. Owens & Minor has transformed its operations over the years through a combination of organic growth and strategic acquisitions, the most notable being the acquisition of Apria, Inc. in March 2022 for approximately $1.7 billion. This acquisition marked a significant expansion into the home healthcare market.

The company’s business is segmented into two main areas: Products & Healthcare Services and Patient Direct. Owens & Minor operates in approximately 80 countries, offering products and services that cater to healthcare providers, hospitals, and patients.

B. Business Segments

Products & Healthcare Services

In the Products & Healthcare Services segment, Owens & Minor provides a comprehensive portfolio of medical and surgical supplies, combining its own proprietary products with those sourced from well-known manufacturers. The segment features a vertically integrated structure that encompasses production, distribution, storage, and sales. This integration allows for efficiency and cost-effectiveness in delivering medical supplies.

Manufacturing Processes

Owens & Minor manufactures a variety of medical supplies, including surgical drapes, gowns, facial protection, medical gloves, and custom procedure kits. Manufacturing takes place in various facilities across the U.S., Thailand, Honduras, Mexico, and Ireland. The manufacturing processes utilize raw materials such as polypropylene and nitrile, with purchasing decisions directed by factors including quality assurance, cost-effectiveness, and regulatory compliance.

Distribution and Logistics

The company operates a network of strategically located distribution centers across the U.S., focusing on optimizing delivery schedules and inventory management to improve healthcare providers' operational efficiency. Services offered include supplier management, clinical supply management, and analytics. Automated systems and technologies, such as voice-pick technology and low-unit-of-measure picking modules, enhance warehouse operations to ensure accuracy and speed in fulfillment.

Customer Relationships

Owens & Minor serves a diverse customer base which includes hospitals, healthcare providers, and surgery centers, often engaging with Group Purchasing Organizations (GPOs) for contract negotiations. The company operates on various pricing models, including cost-plus and fee-for-service arrangements, allowing it to align its offerings with customer needs.

Patient Direct

The Patient Direct segment focuses on the provision of disposable medical supplies directly to patients and home health agencies, making it a leading player in the U.S. home healthcare market. This segment provides products for various home care needs, including diabetes management, respiratory therapy, and wound care.

Services Offered

Patient Direct supplies a wide range of medical equipment and consumables, and it is characterized by a commitment to delivering high-quality care at low costs. Services include comprehensive clinical support for patients, most of whom receive prescriptions as part of individualized care plans. The segment relies heavily on fee-for-service and capitation models, which involve relationships with Medicare, Medicaid, and private insurers for reimbursements.

Distribution Network

To optimize service delivery, the Patient Direct team operates a nationwide sales force and over 300 locations across the U.S. This expansive network enhances the company's ability to efficiently deliver supplies and services to patients in their homes.

C. Market Position and Competition

Owens & Minor faces stiff competition from major manufacturers and distributors in both the Products & Healthcare Services segment and the Patient Direct segment. Notable competitors include Cardinal Health, Medline Industries, AdaptHealth, and Lincare, among others. The competitive landscape requires constant innovation, effective marketing strategies, and meticulous attention to quality to maintain and grow market share.

D. Research and Development

The company invests in research and development to innovate and improve its product offerings. Focus areas typically include enhancing the safety and reliability of existing products while introducing new solutions. This ongoing commitment to R&D ensures that Owens & Minor remains responsive to the evolving demands of the healthcare field and can effectively compete with its peers.

E. Intellectual Property and Regulation

Owens & Minor places substantial importance on intellectual property, holding approximately 825 patents and trademark registrations relevant to its product lines. Compliance with regulations governing product safety, privacy, and environmental standards is paramount, as the company adheres strictly to laws applicable to the healthcare sector.

The regulatory environment is complex, with ongoing oversight from various federal and state agencies ensuring adherence to healthcare-related laws. Compliance requirements can significantly impact operational costs and business strategies, demanding continual vigilance and adaptation from the company.

F. Asset Management

Efficient asset management is crucial for Owens & Minor's profitability, necessitating effective inventory control and accounts receivable management strategies. The company actively monitors inventory levels to avoid obsolescence while employing robust credit management practices to minimize risks associated with customer non-payment.

By ensuring high-quality service through logistical excellence and a strong focus on customer relationships, Owens & Minor positions itself as a trustworthy partner within the global healthcare supply chain.

Stock Infos

SectorHealth Care
IndustryHealth Services
CEOEdward A. Pesicka

Dividends

Copyright ©2026 Taurigo GmbH. All rights reserved.Taurigo GmbH provides no investment advice. Any analyses, research, ideas, prices, or other information contained on this website are provided as general market information for educational and entertainment purposes only, and do not constitute investment advice. We assume no responsibility for the accuracy, completeness or timeliness of any financial information contained on this site. In particular, we do not constitute an invitation to buy, sell or hold securities or other financial products. We shall not be liable for any loss or damage, including without limitation loss of profits, arising directly or indirectly from use of or reliance on the provided information. Before making any investment decision, you should consider whether it is suitable for your situation and obtain appropriate financial, tax and legal advice.